Loading
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
$1.76
−$0.02 · -1.12%
Akanda Corp., operating through its various subsidiary entities, focuses on the cultivation, production, and distribution of cannabis products. The company's operations span the United Kingdom, Lesotho, and other global regions, with a specific aim to provide cannabis-derived items for medical and wellness purposes. Formed in 2021, Akanda Corp. is based out of its main office in New Romney, United Kingdom.
Previous close
$1.76
−$0.02 · -1.12%
Regular session · ET · Market data may be delayed.
Akanda Corp., operating through its various subsidiary entities, focuses on the cultivation, production, and distribution of cannabis products. The company's operations span the United Kingdom, Lesotho, and other global regions, with a specific aim to provide cannabis-derived items for medical and wellness purposes. Formed in 2021, Akanda Corp. is based out of its main office in New Romney, United Kingdom.
Day range
Current $1.76
52-week range
Current $1.76
Regular session · ET · Market data may be delayed.
GoAI Score
Strong sell
Valuation
2
Overpriced
Sentiment
51
Mixed
Risk
72
High Risk
Momentum
19
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Akanda Corp., operating through its various subsidiary entities, focuses on the cultivation, production, and distribution of cannabis products. The company's operations span the United Kingdom, Lesotho, and other global regions, with a specific aim to provide cannabis-derived items for medical and wellness purposes. Formed in 2021, Akanda Corp. is based out of its main office in New Romney, United Kingdom.
Day range
Current $1.76
52-week range
Current $1.76
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 258.08K USD | 836.66K USD | 2.16M USD | 2.62M USD | 41.43K USD |
| Cost of goods sold | 414.1K USD | 628.28K USD | 2.05M USD | 649.88K USD | 756.16K USD |
| Gross profit | −156.02K USD | 208.38K USD | 111.45K USD | 3.27M USD | −714.73K USD |
| Selling, general, and administrative | 4.39M USD | 4.45M USD | 5.88M USD | 19.85M USD | 5.81M USD |
| Operating expenses | 4.83M USD | 4.59M USD | 10.16M USD | 22.15M USD | 6.12M USD |
| Interest income | — | 6.49K USD | 39 USD | 886 USD | 90 USD |
| Interest expense | 925.09K USD | 100.11K USD | 255.66K USD | 115.32K USD | 10.51K USD |
| Depreciation and amortization | 433.69K USD | 141.05K USD | 4.28M USD | 3.76M USD | 309.02K USD |
| Operating income | −4.98M USD | −4.38M USD | −10.05M USD | −20.18M USD | −2.57M USD |
| Net income | −45.65M USD | −4.1M USD | −32.28M USD | −11.66M USD | −8.13M USD |
Company facts updated Oct 11, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Apr 13, 2026 | 2:9 | — | — |
Stock split | Jan 12, 2026 | 1:5 | — | — |
Stock split | Aug 26, 2025 | 8:25 | — | — |
Stock split | Nov 14, 2024 | 1:2 | — | — |
Stock split | May 23, 2024 | 1:40 | — | — |
Stock split | Mar 9, 2023 | 1:10 | — | — |
Effective Apr 13, 2026
2:9
Effective Jan 12, 2026
1:5
Effective Aug 26, 2025
8:25
Effective Nov 14, 2024
1:2
Effective May 23, 2024
1:40
Effective Mar 9, 2023
1:10
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
